4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066818
Chief Legal Officer gave up 854 shares (to pay taxes)
- Chief Legal Officer acquired 2,808 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2017-12-15 | Option exercise | +1,733 | 78,438 | D: show line 1 in the form | ||
| Ali-Jackson Kamil Chief Legal Officer | 2017-12-15 | Shares withheld for taxes | −527 | $24.23 | $12,769 | 77,911 | D: show line 2 in the form |
| Ali-Jackson Kamil Chief Legal Officer | 2017-12-18 | Option exercise | +1,075 | 78,986 | D: show line 3 in the form | ||
| Ali-Jackson Kamil Chief Legal Officer | 2017-12-18 | Shares withheld for taxes | −327 | $24.12 | $7,887 | 78,659 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2017-12-15 | Option exercise · Restricted Stock Units | −1,733 | 12,133 | D: show line 5 in the form | |||||
| Ali-Jackson Kamil Chief Legal Officer | 2017-12-18 | Option exercise · Restricted Stock Units | −1,075 | 2,150 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…